Company news
Sensei Biotherapeutics, Inc. news in 2021
Sensei Biotherapeutics, Inc.'s news releases, calls and decks from 2021, newest first.
Sensei Biotherapeutics Named a Winner of Comparably’s Best CEO Award
December 15, 2021
Sensei Biotherapeutics Announces Addition to the Nasdaq Biotechnology Index
December 12, 2021
Sensei Biotherapeutics to Participate in the Piper Sandler 33rd Annual Healthcare Conference
November 18, 2021
Sensei Biotherapeutics Presents Preclinical Data for SNS-101, a pH-Selective Anti-VISTA Antibody, at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting
November 11, 2021
Sensei Biotherapeutics Reports Third Quarter 2021 Results and Recent Business Highlights
November 8, 2021
Sensei Biotherapeutics to Participate in the Berenberg Virtual U.S. CEO Conference on Tuesday, November 9, 2021
November 2, 2021
Sensei Biotherapeutics to Present New Preclinical Data for SNS-101, a Proprietary Anti-VISTA Antibody, at the 36th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
September 30, 2021
Sensei Biotherapeutics Reports Second Quarter 2021 Results and Highlights Recent In Vivo Data from SNS-VISTA Program
August 3, 2021
Sensei Biotherapeutics Appoints Kristian Humer to its Board of Directors
August 1, 2021
Sensei Biotherapeutics Announces Prioritization of Next-Generation Multi-Antigenic ImmunoPhage Platform, Monoclonal Antibody and Nanobody Programs
June 27, 2021
Sensei Biotherapeutics Announces New Clinical Data from the Ongoing Phase 1/2 Combination Trial of SNS-301 in Patients with Squamous Cell Carcinoma of the Head and Neck
May 18, 2021
Sensei Biotherapeutics Reports First Quarter 2021 Results and Provides Business Update
May 11, 2021
Sensei Biotherapeutics Appoints Maura Gillison, M.D., Ph.D., and Richard Ulevitch, Ph.D., to its Immuno-Oncology Advisory Board
May 4, 2021
Sensei Biotherapeutics Appoints Jessie M. English, Ph.D. to its Board of Directors
April 4, 2021
Sensei Biotherapeutics Reports Full Year 2020 Results and Provides Business Update
March 24, 2021
Sensei Biotherapeutics Announces Inclusion in Russell 2000 Index
March 21, 2021
Sensei Biotherapeutics Announces Closing of Initial Public Offering
February 9, 2021
Sensei Biotherapeutics Announces Pricing of Upsized Initial Public Offering
February 2, 2021
Calls in 2021
Decks in 2021
- Investor Presentation (December 2021)
Investor deck · 34 slides · Dec 6, 2021
- Technical Presentation (November 2021)
Technical · 37 slides · Nov 16, 2021
- Investor Presentation (September 2021)
Investor deck · 30 slides · Sep 8, 2021